InMed Pharmaceuticals (INM) Liabilities from Discontinued Operations (2025 - 2026)
InMed Pharmaceuticals (INM) posted Liabilities from Discontinued Operations of $810334.0 for Q1 2026, up 367.22% on a QoQ basis from $173438.0 in Q2 2025.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Liabilities from Discontinued Operations (2025 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at $810334.0 in Q1 2026.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $810334.0 in Q1 2026; TTM through Mar 2026 was $810334.0, a N/A change from a year earlier, with the FY2025 full-year figure at $173438.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was $810334.0 for Q1 2026 at InMed Pharmaceuticals, up from $173438.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was $810334.0 in Q1 2026, with the low at $173438.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Corning | 145.51 Bn | 143.00 Bn | 1.63 Bn |
| 2 | Ati | 28.39 Bn | 27.61 Bn | 309.80 Mn |
| 3 | Qnity Electronics | 26.40 Bn | 25.43 Bn | 666.00 Mn |
| 4 | International Flavors & Fragrances | 21.55 Bn | 20.98 Bn | 853.00 Mn |
| 5 | DuPont de Nemours | 17.47 Bn | 15.73 Bn | 639.00 Mn |
| 6 | Avery Dennison | 13.02 Bn | 12.80 Bn | 729.40 Mn |
| 7 | Solstice Advanced Materials | 10.12 Bn | 9.37 Bn | 370.00 Mn |
| 8 | Element Solutions | 8.76 Bn | 8.57 Bn | 334.00 Mn |
| 9 | Eastman Chemical | 7.85 Bn | 7.16 Bn | 560.00 Mn |
| 10 | InMed Pharmaceuticals | 5.32 Mn | 81,770.07 | - |